Systematic evaluation of 99mTc-tetrofosmin versus 99mTc-sestamibi to study murine myocardial perfusion in small animal SPECT/CT

被引:10
|
作者
Vrachimis, Alexis [1 ,2 ]
Hermann, Sven [1 ]
Mathe, Domokos [3 ]
Schober, Otmar [2 ]
Schaefers, Michael [1 ,2 ]
机构
[1] Univ Munster, European Inst Mol Imaging, D-48149 Munster, Germany
[2] Univ Hosp Muenster, Dept Nucl Med, D-48149 Munster, Germany
[3] Semmelweis Univ, Dept Biophys & Radiat Biol, Fac Med, Nanobiotechnol & In Vivo Imaging Ctr, H-1085 Budapest, Hungary
来源
EJNMMI RESEARCH | 2012年 / 2卷
关键词
Multi-pinhole SPECT; Myocardial perfusion; MIBI; Tetrofosmin; Mouse; COMPUTED-TOMOGRAPHY; MAGNETIC-RESONANCE; IMAGING AGENT; TECHNETIUM-99M-TETROFOSMIN; RATS;
D O I
10.1186/2191-219X-2-21
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: The "back-translation" of clinically available protocols to measure myocardial perfusion to preclinical imaging in mouse models of human disease is attractive for basic biomedical research. With respect to single-photon emission computed tomography (SPECT) approaches, clinical myocardial perfusion imaging protocols are established with different Tc-99m-labeled perfusion tracers; however, studies evaluating and optimizing protocols for these tracers in high-resolution pinhole SPECT in mice are lacking. This study aims at evaluating two clinically available Tc-99m-labeled myocardial perfusion tracers (Tc-99m-sestamibi vs. Tc-99m-Tetrofosmin) in mice using four different imaging protocols. Methods: Adult C57BL/6 male mice were injected with Tc-99m-sestamibi (MIBI) or Tc-99m-Tetrofosmin (TETRO) (4 MBq/g body weight) either intravenously through the tail vein (n = 5) or retroorbitally (n = 5) or intraperitoneally (i.p.) under anesthesia (n = 3) or i.p. in an awake state (n = 3) at rest. Immediately after injection, a multi-frame single-photon emission computed tomography/computed tomography (SPECT/CT) acquisition was initiated with six subsequent time frames of 10 min each. Reconstructed images of the different protocols were assessed and compared by visual analysis by experts and by time-activity-curves generated from regions-of-interest for various organs (normalized uptake values). Results: Visually assessing overall image quality, the best image quality was found for MIBI for both intravenous injection protocols, whereas TETRO only had comparable image quality after retroorbital injections. These results were confirmed by quantitative analysis where left ventricular (LV) uptake of MIBI after tail vein injections was found significantly higher for all time points accompanied with a significantly slower washout of 16% for MIBI vs. 33% for TETRO (p = 0.009) from 10 to 60 min post injection (PI). Interestingly, LV washout from 10 to 60 min PI was significantly higher for TETRO when applied by tail vein injections when compared to retroorbital injections (22%, p = 0.008). However, liver uptake was significant and comparable for both tracers at all time points. Radioactivity concentration in the lungs was negligible for all time points and both tracers. Conclusion: Intravenous MIBI injection (both tail vein and retroorbital) results in the best image quality for assessing myocardial perfusion of the murine heart by SPECT/CT. TETRO has a comparable image quality only for the retroorbital injection route.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Systematic evaluation of 99mTc-tetrofosmin versus 99mTc-sestamibi to study murine myocardial perfusion in small animal SPECT/CT
    Alexis Vrachimis
    Sven Hermann
    Domokos Máthé
    Otmar Schober
    Michael Schäfers
    EJNMMI Research, 2
  • [2] Performance of 99mTc-tetrofosmin versus 99mTc-sestamibi in murine myocardial perfusion studies
    Vrachimis, Alexis
    Hermann, Sven
    Schober, Otmar
    Schafers, Michael
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [3] Efficiency comparison between 99mTc-tetrofosmin and 99mTc-sestamibi myocardial perfusion studies
    Ravizzini, GC
    Hanson, MW
    Shaw, LK
    Wong, TZ
    Hagge, RJ
    Pagnanelli, RA
    Jain, D
    Lima, HS
    Coleman, RE
    Borges-Neto, S
    NUCLEAR MEDICINE COMMUNICATIONS, 2002, 23 (03) : 203 - 208
  • [4] Comparison of 99mTc-sestamibi and 99mTc-tetrofosmin washoutratesfrom parathyroid and thyroid glands
    Athanasoulis, T.
    Valsamaki, P.
    Karantanis, D.
    Daramaras, A.
    Jianakopoulou, P.
    Katsoulis, A.
    Zerva, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S232 - S233
  • [5] 99mTc-tetrofosmin or 99mTc-sestamibi for double-phase parathyroid scintigraphy?
    Fröberg, AC
    Valkema, R
    Bonjer, HJ
    Krenning, EP
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (02) : 193 - 196
  • [6] 99mTc-tetrofosmin or 99mTc-sestamibi for double-phase parathyroid scintigraphy?
    Alida C. Fröberg
    Roelf Valkema
    Jaap H. Bonjer
    Eric P. Krenning
    European Journal of Nuclear Medicine and Molecular Imaging, 2003, 30 : 193 - 196
  • [7] Efficiency comparison between 99mTc-tetrofosmin and 99mTc-sestamibi myocardial perfusion studies (vol 23, pg 203, 2002)
    Ravizzini, GC
    Hanson, MW
    Shaw, LK
    Wong, TZ
    Hagge, RJ
    Pagnanelli, RA
    NUCLEAR MEDICINE COMMUNICATIONS, 2006, 27 (04) : 411 - 411
  • [8] 99mTc-Tetrofosmin or 99mTc-Sestamibi for double-phase parathyroid scintigraphy.
    Fröberg, AC
    Valkema, R
    Bonjer, HJ
    Krenning, EP
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 326P - 326P
  • [9] Influence of subdiaphragmatic activity on the clinical interpretation of myocardial perfusion SPECT: comparison between 99mTc-tetrofosmin and 99mTc-sestamibi.
    Delsarte, P.
    Hambye, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S287 - S287
  • [10] 99mTc-N-DBODC5, a new myocardial perfusion imaging agent with rapid liver clearance:: Comparison with 99mTc-sestamibi and 99mTc-tetrofosmin in rats
    Hatada, K
    Riou, LM
    Ruiz, M
    Yamamichi, Y
    Duatti, A
    Lima, RL
    Goode, AR
    Watson, DD
    Beller, GA
    Glover, DK
    JOURNAL OF NUCLEAR MEDICINE, 2004, 45 (12) : 2095 - 2101